Patients with ANCA-associated vasculitis are at risk for life-threatening complications, organ damage, toxic effects from medications used to treat the disorder, and deterioration of health-related quality of life. Treatments that increase the likelihood of sustained remission are needed. New research findings are summarized in a short video. https://nej.md/3rUaVgd | The New England Journal of Medicine